Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Non-Hodgkin 4Lymphoma 4Prostatic Neoplasms 3Leukemia 3Hematologic Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, B-Cell 2Lung Neoplasms 2Carcinoma in Situ 2Burkitt Lymphoma 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Initiation and Maintenance Disorders 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Peritoneal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1

Interventions

Erlotinib Hydrochloride 3Bevacizumab 3Radiotherapy 2Filgrastim 2Cetuximab 2sargramostim 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1enasidenib 1aldesleukin 1Vorinostat 1Tomography, X-Ray Computed 1Thiotepa 1Ritonavir 1Radionuclide Imaging 1Radiation 1Positron-Emission Tomography 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Irinotecan 1Indinavir 1Ibuprofen 1Hydroxyurea 1Granulocyte Colony-Stimulating Factor 1Gefitinib 1Fluorouracil 1Etoposide 1Epirubicin 1Electrocardiography 1E6 protein, Human papillomavirus type 16 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Esthesioneuroblastoma, Olfactory × Electrocardiography × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡